sb.scorecardresearch
Advertisement

Published 20:15 IST, October 16th 2020

WHO backs remdesivir trial data after Gilead terms it inconsistent with 'robust evidence'

WHO trial data on Gilead Sciences Inc.'s remdesivir is reliable, said an independent statistician hired by the UN health agency to evaluate the results.

Reported by: Kunal Gaurav
Follow: Google News Icon
  • share
WHO
null | Image: self
Advertisement

Loading...

20:15 IST, October 16th 2020